Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06660680Phase 3Enrolling by invitation
A Phase 3 trial of methylene blue in hemorrhoid. Started Oct 2024; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06660680.